The heart in inflammatory bowel disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 12: | Line 12: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 16:49, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Inflammatory bowel disease (IBD) has been associated with the development of pericarditis and or myocarditis in one third of IBD patients. Treatement with drugs containing 5-aminosalicylic acid have been associated with the development of pericarditis in inflammatory bowel disease.[1] Those with Crohn's disease seem to be at a lower risk than ulcerative colitis. Ulcerative colitis may also be associated with endocarditis as well.[2] The presence of pericarditis may predate the diagnosis of inflammatory bowel disease.
References